HLTH
ThematicVanEck Global Healthcare Leaders ETF
About this ETF
The Fund gives investors access to a portfolio of leading international developed markets companies with the best growth at a reasonable price (‘GARP’) attributes from the global health care sector.
Scout Score
An independent score calculated by ETF Scout across 7 real-data factors (cost, diversification, tracking, liquidity, fund strength, performance, income), ranked against other funds in the same category.
Strengths
- Tight index tracking — 14.61% tracking error, tighter than 82% of Thematic peers.
- Low fee — 0.45% p.a., cheaper than 78% of Thematic funds.
Weaknesses
- Lower liquidity — 0.38% bid/ask spread, wider than 75% of Thematic peers.
- Below-average yield — 0.32%, lower than 72% of Thematic peers.
Performance (as of 31 Oct 2026)
Total returns, net of fees. Periods longer than 1 year are annualised.
Price history
Cumulative return over the selected period, indexed to 0% at the start of the range.
Geographic exposure (as at 4 Nov 2026)
Country (where the company is based).
Sector breakdown (as at 4 Nov 2026)
How your portfolio's holdings are spread across GICS sectors.
Top holdings (as of 4 Nov 2026)
The fund's largest individual holdings, ranked by portfolio weight.
- 1.
Idexx Laboratories Inc2.51%
- 2.Mettler-Toledo International Inc2.42%
- 3.
Ucb SA2.41%
- 4.
Intuitive Surgical Inc2.37%
- 5.Exelixis Inc2.35%
- 6.
Eli Lilly & Co2.30%
- 7.
Amgen Inc2.30%
- 8.Orion Oyj2.27%
- 9.
Insulet Corp2.27%
- 10.
Stryker Corp2.23%
- 11.United Therapeutics Corp2.22%
- 12.
Zoetis Inc2.22%
- 13.Halozyme Therapeutics Inc2.20%
- 14.
Agilent Technologies Inc2.19%
- 15.Alk-Abello A/S2.18%
- 16.
Astrazeneca plc2.16%
- 17.
Regeneron Pharmaceuticals Inc2.16%
- 18.Globus Medical Inc2.13%
- 19.Encompass Health Corp2.10%
- 20.Tg Therapeutics Inc2.07%
